Rush University Medical Center


Rush Medical Center Initiates HERO-HCQ Study in Chicago: Will Hydroxychloroquine Help Protect Healthcare Workers from COVID-19?

Rush University Medical Center opened up enrollment for the HERO-HCQ clinical trial to determine whether hydroxychloroquine is better than a placebo in preventing COVID-19 in healthy people working in a health care setting. With its full title as the Healthcare Worker...

Washington University & Rush University Med. Center In Pursuit of Reprogramming Pancreatic Cancer—Phase I Clinical Trials Coming Soon

Washington University School of Medicine, St. Louis and Rush University Medical Center, Chicago investigators have found that a type of white blood cell called tumor-associated macrophages that been deceived by pancreatic cancer cells into not attacking them can be...

Pin It on Pinterest